AstraZeneca continues hunt for RNA-based therapies

04/2/2013 | Bloomberg

AstraZeneca CEO Pascal Soriot is forging ahead with efforts to discover drugs based on RNA technology with its partnership with biotech company Moderna Therapeutics. Moderna's platform allows fast, simultaneous testing on multiple targets for messenger RNA. The company is also working on antisense therapies in partnership with Isis Pharmaceuticals.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY